Brief: NGM Biopharmaceuticals Posts Quarterly Loss Per Share $0.28

NGM Biopharmaceuticals

13/05/2020 22:06

May 13 (Reuters) - NGM Biopharmaceuticals Inc  NGM.O :
    * NGM BIO PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER
2020
FINANCIAL RESULTS
    * $328.5 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES AS OF MARCH 31, 2020
    * NGM BIOPHARMACEUTICALS - RELATED PARTY REVENUE FROM
COLLABORATION WITH MERCK FOR QUARTER ENDED MARCH 31, 2020 WAS
$24.4 MILLION
    * QTRLY LOSS PER SHARE $0.28
    * IMPACT OF COVID-19 PANDEMIC, TO DATE, HAS NOT RESULTED IN
A
SIGNIFICANT IMPACT TO COMPANY'S DEVELOPMENT TIMELINES
    * REMAIN ON TRACK WITH ALL PREVIOUSLY PROVIDED CLINICAL
TRIAL
TIMING GUIDANCE
    * Q1 EARNINGS PER SHARE VIEW $-0.27, REVENUE VIEW $23.0
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3wGg4d 
Further company coverage:  NGM.O 

 ((Reuters.Briefs@thomsonreuters.com;))